Pharmacists' ability to influence outcomes of hypertension therapy

Pharmacotherapy

Volumn 17, Issue 1, 1997, Pages 140-147

  Erickson, Steven R ^a,b   Slaughter, Richard ^a   Halapy, Henry ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; OUTPATIENT CARE; PHARMACEUTICAL CARE; PHARMACIST; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

AGED; AMBULATORY CARE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT CARE TEAM; PHARMACISTS; PILOT PROJECTS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 0031016831     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1973;63:1104-11.
2. Hatoum HT, Akhras K. 1993 bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Ann Pharmacother 1993;27:1106-19.
3. Mason JD, Colley CA. Effectiveness of an ambulatory care clinical pharmacist: a controlled trial. Ann Pharmacother 1993;27:555-9.
4. Klopfer JD, Einarson TR. Acceptance of pharmacists' suggestions by prescribers: a literature review. Hosp Pharm 1990;25:830-2, 834-6.
5. Tamai IY, Rubenstein LZ, Josephson KR, Yamauchi JA. Impact of computerized drug profiles and a consulting pharmacist on outpatient prescribing patterns: a clinical trial. Drug Intell Clin Pharm 1987;21:890-5.
6. Haxby DG, Weart CW, Goodman BW. Family practice physicians' perceptions of the usefulness of drug therapy recommendations from clinical pharmacists. Am J Hosp Pharm 1988;45:824-7.
7. Deady JE, Lepinski PW, Abramowitz PW. Measuring the ability of clinical pharmacists to effect drug therapy changes in a family practice clinic using prognostic indicators. Hosp Pharm 1991;26:93-7.
8. Britton ML, Lurvey PL. Impact of medication profile review on prescribing in a general medicine clinic. Am J Hosp Pharm 1991;48:265-70.
9. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
10. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: results from the medical outcomes study. JAMA 1989;262:907-13.
11. Tarlov AR, Ware JE, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The medical outcomes study: an application of methods for monitoring the results of medical care. JAMA 1989;262:925-30.
12. Ware JE, Sherbourne CD. The MOS 36-item Short-form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
13. Ware JE. SF-36 Health Survey: manual interpretation guide. Boston: The Health Institute, 1993.
14. Bulpitt CJ, Fletcher AE. The measurement of quality of life in hypertensive patients: a practical approach. Br J Clin Pharmacol 1990;30:353-64.
15. Bulpitt CJ, Dollery CT, Carne S. Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976;38:121-8.
16. Bulpitt CJ, Dollery CT, Carne S. A symptom questionnaire for hypertensive patients. J Chron Dis 1974;27:309-23.
17. Bulpitt CJ, Dollery CT. Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J 1973;3:485-90.
18. The Joint National Committee. The fifth report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-83.
19. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255-64.
20. Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish trial in old patients with hypertension. Lancet 1991;338:1281-5.
21. Hypertension and Follow-Up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. 1. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242: 2567-71.
22. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. JAMA 1967;202:1028-34.
23. Management Committee. The Australian therapeutic trail in mild hypertension. Lancet 1980;1:1261-9.
24. Helgeland A. Treatment of mild hypertension: a five-year controlled drug trial. The Oslo study. Am J Med 1980; 69:725-32
25. Medical Research Council Working Party. Medical research council trial of treatment of mild hypertension: principal results Br Med J 1985;291:97-104.
26. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982;248:1465-77.
27. Multiple Risk Factor Intervention Trial Research Group. Mortality after 10 1/2 years for hypertensive participants in the multiple risk factor intervention trial. Circulation 1990;82:1616-28.
28. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of mild hypertension study. Final results. JAMA 1993;270:713-24.
29. Haynes RB, Sacket DL, Taylor DW, et al. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 1978;299:741-4.
30. Mossey JM. Psychosocial consequences of labeling in hypertension. Clin Invest Med 1981;4:201-7
31. Harlan LC, Polk F, Cooper S, et al. Effects of labeling and treatment of hypertension on perceived health. Am J Prev Med 1986;2:256-61.
32. Lefebvre RC, Hursey KG, Carleton RA. Labeling of participants in high blood pressure screening programs. Implications for blood cholesterol screenings. Arch Intern Med 1988;148:1993-7.